Third edition - WHO
Dr Murray L. Cohen, Centers for Disease Control and Prevention, Atlanta, GA, USA (retired) Dr Ingegerd Kallings, Swedish Institute of Infectious Disease Control, Stockholm, Sweden Ms Mary Ellen Kennedy, Consultant in Biosafety, Ashton, Ontario, Canada Ms Margery Kennett, Victorian Infectious Diseases Reference Laboratory, North Mel-
Download Third edition - WHO
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
Macroeconomics, Investing in health for economic, Investing, Health, Economic, Investing in health for economic development, Development
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Good practices for pharmaceutical microbiology laboratories, Laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Health, Heterotrophic plate count measurement in, Heterotrophic, Plate, Count, Measurement, World health organization, World, Organization
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Good, Practices, Pharmaceutical, Good distribution practices for, Distribution
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Laboratories, Pharmaceutical microbiology laboratories
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Health, Manual, Laboratory, World health organization, World, Organization, Laboratory biosafety manual, Biosafety
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Manual, Laboratory, Mycobacteriology laboratory manual, Mycobacteriology
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Guidelines, Laboratory, Laboratory guidelines for enumerating cd4, Enumerating
Related documents
Biosafety in Microbiological and Biomedical Laboratories
www.cdc.govCenters for Disease Control and Prevention Julia K. Hilliard, PhD . Viral Immunology Center, Department of Biology Georgia State University William C. Howard, MS . Industrial Hygiene/Safety Manager Office of Health and Safety Centers for Disease Control and Prevention Herbert Jacobi . Deputy Director Division of Occupational Health and Safety
Laboratories, Center, Control, Microbiological, Biosafety, Centers for disease control and prevention, Disease, Prevention, Biomedical, Biosafety in microbiological and biomedical laboratories
Leptospirosis in cattle herds - Department of Primary ...
www.dpi.nsw.gov.auleptospirosis infection. Public health aspects The infection is an important and continuing public health problem in rural areas. Beef and dairy producers and people employed on farms are at risk of contracting leptospirosis during normal cattle handling activities. Leptospirosis in humans is a notifiable disease in Australia.
Infections, Cattle, Herd, Leptospirosis, Leptospirosis in cattle herds
Common Diseases and Health Problems in Sheep and Goats
www.extension.purdue.eduPrevention of Disease Biosecurity begins with the goal of preventing the spread of infectious agents from infected to susceptible animals. A biosecurity plan must take into account all modes of transmission, including direct animal contact within a herd, contact with wild animals or other domesticated species, airborne transmission,
Health, Disease, Prevention, Problem, Biosecurity, Common, Common diseases and health problems in
African swine fever (ASF) detection and diagnosis
www.fao.orgPrevention and control 57 Awareness 57 Prevention 59 Swill feeding 60 Containment of pigs 60 Cleaning and disinfection 61 Other biosecurity measures 62 Risk analysis and import/export procedures 63 Control 63 Emergency planning 64 Legal framework 65 Financing 65 Communication 66 Movement control 66 Stamping out and disposal 67 Cleaning and ...
PREVENTION, DETECTION AND CONTROL OF SALMONELLA …
www.oie.intChapter6.5.on Biosecurity Procedures in Poultry Production. ... Additional prevention and control measures include vaccination, competitive exclusion, use of organic acids, culling and product diversion to processing. Antimicrobial agents should not be used to control infection with Salmonella in poultry because the effectiveness of the ...
Control, Prevention, Biosecurity, Infections, Infection control
Western Australian Government Pandemic Plan
www.wa.gov.au• Risk groups for severe and fatal infection cannot be predicted with certainty but may include infants, the elderly, pregnant women, persons with chronic or immunosuppressive medical conditions, and Aboriginal and Torres Strait Islander peoples. • The spread of disease can be limited by prevention and preparedness actions.